Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population
Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population
RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) reported on Friday its third quarter results for the three months ended Sept. 30, revealing a 28% sequential, and 186% year-over-year, increase in net revenue to $4.9 million.
RIV Capital Inc. (cse:RIV) (場外交易:CNPOF) 在週五報告了截至9月30日的第三季度業績,淨營業收入同比增長28%,年增長186%,達到了490萬美元。
Out of that sum, retail revenue accounted for $3.4 million, up from $1.5 million in the third quarter, reflecting strong growth from adult-use dispensaries in New York. Wholesale revenue surged to $1.6 million, up from $0.3 million over the same period, the company said in a press release.
其中,零售營業收入佔334萬美元,較第三季度的150萬美元增長,反映了紐約成人使用藥房的強勁增長。批發營業收入激增至160萬美元,比同期的30萬美元大幅增長,公司在新聞稿中表示。
RIV Capital, a company focused on building a multi-state platform with a portfolio of cannabis brands and the operator of the Etain brand in New York, is planning to merge with Cansortium Inc. (CSE:TIUM) (OTCQB:CNTMF), which operates under the FLUENT brand. The merger, expected to close in early December 2024, aims to position the combined company to serve 25% of the U.S. population, with eight cultivation and processing facilities and 42 retail dispensaries across key markets.
RIV Capital是一家專注於建立多州平台的公司,擁有大麻品牌的投資組合,並且是紐約Etain品牌的運營商,計劃與Cansortium Inc.(cse:TIUM)(OTCQB:CNTMF)合併,該公司在FLUENt品牌下運營。預計合併將在2024年12月初完成,旨在使合併後的公司能夠服務於美國25%的人口,並在關鍵市場中擁有八個種植和加工設施以及42個零售藥房。
"Since announcing the proposed Business Combination with Cansortium, we've identified and captured substantial synergies, and our joint integration efforts are progressing smoothly," Dave Vautrin, the company's chief retail officer and interim CEO, said. "With Cansortium, we're poised to complete this transaction on a solid foundation and positioned to quickly capitalize on the combined expertise and experience of our teams in some of the most dynamic markets in the cannabis industry."
"自宣佈與Cansortium的業務合併提案以來,我們已識別並捕捉到大量協同效應,我們的聯合整合工作正在順利進行," 公司首席零售官和臨時首席執行官Dave Vautrin表示。"與Cansortium合作,我們準備在堅實的基礎上完成這一交易,並迅速利用我們團隊在大麻行業一些最具活力市場中的專業知識和經驗。"
Read Also: Cannabis Co. Cansortium Refinances Debt With $96.5M Loan Ahead Of Major Merger And Next Phase Of Growth
另請閱讀:大麻公司Cansortium在重大合併和下一階段增長之前,以9650萬美元的貸款進行債務再融資
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
- 訂閱本新聞快訊,每天免費獲取Benzinga獨家分析和大麻股行業及市場的最新資訊。如果您對業務認真,不容錯過。在這裏訂閱我們的新聞簡報。
Q3 2024 Financial Highlights
2024年Q3財務亮點:
- Net loss was $63.4 million, compared to a net loss of $7.4 million in the prior year's period, driven by a $67.4 million non-cash impairment of intangible assets related to the acquisition of Etain LLC's cannabis license rights and brands.
- Gross loss was $1.2 million, compared to a gross profit of $51,000 in the same period last year.
- Selling, general and administrative expenses decreased to $4.6 million, down from $4.8 million in the third quarter of the past fiscal year.
- Adjusted EBITDA, a metric that excludes one-time expenses and non-cash items to reflect operational performance, came in negative at $3.2 million, an improvement compared to the $5 million loss in the prior year's period.
- Net cash flows used in operating activities amounted to $9.3 million for the nine months ended September 30, 2024.
- 淨虧損爲6340萬美元,而前一年同期的淨虧損爲740萬美元,這主要是由於6740萬美元的非現金無形資產減值,涉及收購Etain LLC的大麻許可證權利和品牌。
- 毛損爲120萬美元,而去年同期的毛利潤爲51,000美元。
- 銷售、一般和行政費用減少至460萬,去年第三季度爲480萬。
- 調整後的EBITDA是一個排除一次性費用和非現金項目以反映運營表現的指標,負值爲320萬,相較於去年同期的500萬損失有所改善。
- 截至2024年9月30日的九個月內,經營活動中使用的淨現金流達930萬。
- RIV Capital Partners With Cannabis Wholesale Platform Nabis To Boost New York Distribution
- RIV Capital與大麻股批發平台Nabis合作,以加強紐約的分銷。
譯文內容由第三人軟體翻譯。